V. Craig Jordan - Concepedia

Author

V. Craig Jordan

Also Known As

Jordan, V. Craig, V C Jordan, V Craig Jordan, V Jordan, V. C. JORDAN, V. C. Jordan, V. CRAIG JORDAN, V. Craig Jordan, V. Jordan, V.C Jordan

312

Publications

14.5K

Citations

H-Index

116

Concepts

All Affiliations

University of Wisconsin–Madison Northwestern University Breast Cancer Care Georgetown University University of Wisconsin Carbone Cancer Center

About

V. Craig Jordan is an author at University of Wisconsin–Madison specializing in medicine, breast cancer, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	68	5.2K
2	Natural Sciences	6	6	367
3	Public Health	5	5	295
4	Health Sciences	3	3	64
5	Arts	1	1	11

V. Craig Jordan

103

Publications

9.7K

Citations

H-Index

Page 1

	Year	Citations
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women Steven R. Cummings, Stephen Eckert, K A Krueger, JAMA	1999	1.9K
The estrogen receptor: a model for molecular medicine. Elwood V. Jensen, V. Craig Jordan PubMed Molecular PharmacologyBreast OncologyMedicineEstrogen ActionHormonal Receptor	2003	462
Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata V. Craig Jordan European Journal of Cancer (1965) Tumor BiologyBreast OncologyMedicineIci 46,474Pharmacology	1976	372
Effects of Tamoxifen Therapy on Lipid and Lipoprotein Levels in Postmenopausal Patients With Node-Negative Breast Cancer R. R. Love, Polly A. Newcomb, Donald A. Wiebe, JNCI Journal of the National Cancer Institute	1990	293
Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. S P Robinson, Susan M. Langan-Fahey, D A Johnson, Drug Metabolism and Disposition	1991	272
Estrogen Receptors as Therapeutic Targets in Breast Cancer Eric A. Ariazi, Jennifer L. Ariazi, Fernando Cordera, Current Topics in Medicinal Chemistry Breast OncologyChemoprevention StrategyGynecologyPharmacotherapyTumor Biology	2006	250
The G Protein–Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor–Positive Breast Cancer Cells Eric A. Ariazi, Eugen Brailoiu, Smitha Yerrum, Cancer Research Activate Gpr30Breast OncologyG Protein-coupled ReceptorMedicineHormonal Receptor	2010	234
Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model V. Craig Jordan, Karen E. Allen European Journal of Cancer (1965) Breast OncologyOncologyMedicineBreast CancerPharmacotherapy	1980	214
The Small Heat Shock Protein αB-crystallin Is a Novel Inhibitor of TRAIL-induced Apoptosis That Suppresses the Activation of Caspase-3 Merideth C. Kamradt, Meiling Lü, Michael E. Werner, Journal of Biological Chemistry	2005	211
Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics Housheng Hansen He, Clifford A. Meyer, Mei Wei Chen, Genome Research Histone ModificationsChromatinTranscriptional RegulationAndrogen ReceptorChromatin Structure	2012	186

Page 1